A large, long-term study found that playing a brain training video game may help protect the brain against dementia for decades. Experts say the findings are the strongest evidence yet that cognitive ...
Stroke patients with a cerebral vessel occlusion that is clearly visible on brain imaging are potential candidates for intra-arterial thrombolysis. Preliminary evidence indicates that the NIH Stroke ...
Guideline endorses intravenous tenecteplase or alteplase within the 4.5-hour thrombolytic treatment window. (HealthDay News) — In a guideline issued by the American Heart Association/American Stroke ...
New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care equitably with smart wearables. The future of stroke care is likely to be ...
WALNUT CREEK, Calif., Feb. 18, 2026 /PRNewswire/ -- A Catalight researcher has been awarded a $4.5 million National Institute of Health (NIH) R01 grant to study RUBIES, a program aimed at reducing ...
The National Institutes of Health (NIH) halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) in a phase 3 stroke prevention trial after an independent committee flagged safety ...
The primary aim of this multi-institutional summer research, educational, and professional development training program is to prepare undergraduate students for advanced academic training in PhD and ...
Introduction Common mental health outcomes among children in conflict with the law in correctional facilities in Africa are an under-researched area with significant public health implications. This ...
Hosted on MSN
NIH stops Johnson & Johnson's blood thinner drug arm in stroke trial after safety review
The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke prevention trial. The primary goal of the trial is to determine if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results